[go: up one dir, main page]

AR015211A1 - Amidas aromaticas, su procedimiento de preparacion, composicion farmaceutica y productos quimicos que las contienen - Google Patents

Amidas aromaticas, su procedimiento de preparacion, composicion farmaceutica y productos quimicos que las contienen

Info

Publication number
AR015211A1
AR015211A1 ARP990100061A ARP990100061A AR015211A1 AR 015211 A1 AR015211 A1 AR 015211A1 AR P990100061 A ARP990100061 A AR P990100061A AR P990100061 A ARP990100061 A AR P990100061A AR 015211 A1 AR015211 A1 AR 015211A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
pharmaceutical composition
amidas
aromatic
Prior art date
Application number
ARP990100061A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9800116A external-priority patent/FR2773369B1/fr
Priority claimed from FR9812936A external-priority patent/FR2784681B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR015211A1 publication Critical patent/AR015211A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/075Benzo[b]pyran-2-ones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

El invento tiene por objeto los componentes de la formula (I) en la que X=oxígeno, N-Nalc1 o Noalc2, X=hidrogeno, hidroxilo, alquilo, alquenilo, oalquinilo o bien X=NRcRd, siendo Rc y Rd hidrogeno o alquilo, Z=hidrogeno o halogeno, R2=hidrogeno o halogeno, R3=hidrogeno, alquilo o halogeno, R=hidrogeno oalquilo, R1= hidrogeno, alquilo, alquenilo o alquinilo, R5=hidrogeno u O-alquilo, R6=alquilo o CH2-O-alquilo y R7=hidrogeno o alquilo, o bien R6 y R7 forman,con el átomo de carbono que los lleva,un radical cíclico que contiene hasta 8 átomos de carbono. Los compuestos de formula (I) presentan propiedadesantibioticas, composicion farmacéutica y productos químicos que las comprenden.
ARP990100061A 1998-01-08 1999-01-08 Amidas aromaticas, su procedimiento de preparacion, composicion farmaceutica y productos quimicos que las contienen AR015211A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800116A FR2773369B1 (fr) 1998-01-08 1998-01-08 Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
FR9812936A FR2784681B1 (fr) 1998-10-15 1998-10-15 Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
AR015211A1 true AR015211A1 (es) 2001-04-18

Family

ID=26234055

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100061A AR015211A1 (es) 1998-01-08 1999-01-08 Amidas aromaticas, su procedimiento de preparacion, composicion farmaceutica y productos quimicos que las contienen

Country Status (36)

Country Link
US (2) US6420538B1 (es)
EP (1) EP1045856B1 (es)
JP (1) JP2002500229A (es)
KR (1) KR100604290B1 (es)
CN (2) CN1269833C (es)
AP (1) AP2000001857A0 (es)
AR (1) AR015211A1 (es)
AT (1) ATE236918T1 (es)
AU (1) AU750742B2 (es)
BR (1) BR9906819A (es)
CA (1) CA2317951A1 (es)
CO (1) CO4810298A1 (es)
CZ (1) CZ299840B6 (es)
DE (1) DE69906684T2 (es)
DK (1) DK1045856T3 (es)
DZ (1) DZ2702A1 (es)
EA (1) EA003275B1 (es)
ES (1) ES2192031T3 (es)
HU (1) HUP0100847A3 (es)
ID (1) ID27558A (es)
IL (1) IL137201A0 (es)
MA (1) MA26593A1 (es)
NO (1) NO20003496L (es)
NZ (1) NZ505523A (es)
PA (1) PA8466601A1 (es)
PE (1) PE20000175A1 (es)
PL (1) PL193130B1 (es)
PT (1) PT1045856E (es)
RS (1) RS50047B (es)
SA (1) SA99191247B1 (es)
SI (1) SI1045856T1 (es)
SK (1) SK284734B6 (es)
TN (1) TNSN99003A1 (es)
TR (1) TR200002009T2 (es)
TW (1) TW538046B (es)
WO (1) WO1999035155A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
TW538046B (en) * 1998-01-08 2003-06-21 Hoechst Marion Roussel Inc Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof
US6916846B2 (en) 2000-05-12 2005-07-12 Merck & Co. Inc. Coumermycin analogs as chemical dimerizers of chimeric proteins
EP1341769B1 (en) 2000-12-15 2007-10-17 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8193352B2 (en) 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
TW201026695A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2011024004A1 (en) 2009-08-26 2011-03-03 Astrazeneca Ab Heterocyclic urea derivatives useful for treatment of bacterial infection
WO2011026107A1 (en) 2009-08-31 2011-03-03 University Of Notre Dame Du Lac Phthalanilate compounds and methods of use
WO2012097270A1 (en) 2011-01-14 2012-07-19 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
CA2824519C (en) 2011-01-14 2020-06-16 Vertex Pharmaceuticals Incorporated Process of making gyrase and topoisomerase inhibitors
TWI535714B (zh) 2011-01-14 2016-06-01 維泰克斯製藥公司 旋轉酶抑制劑(r)-1-乙基-3-[6-氟-5-[2-(1-羥基-1-甲基-乙基)嘧啶-5-基]-7-(四氫呋喃-2-基)-1h-苯并咪唑-2-基]脲之固體形式
SG191946A1 (en) 2011-01-14 2013-08-30 Vertex Pharma Pyrimidine gyrase and topoisomerase iv inhibitors
EP2721026B1 (en) 2011-06-20 2016-03-02 Vertex Pharmaceuticals Incorporated Phosphate esters of gyrase and topoisomerase inhibitors
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
AR093226A1 (es) 2012-07-18 2015-05-27 Vertex Pharma Formas solidas de dihidrogeno fosfato de (r)-2-(5-(2-(3-etilureido)-6-fluoro-7-(tetrahidrofuran-2-il)-1h-benzo[d]imidazol-5-il)pirimidin-2-il)propan-2-ilo y sus sales
WO2020048949A1 (en) 2018-09-03 2020-03-12 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
US20250002455A1 (en) 2020-12-17 2025-01-02 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226978A (en) 1978-03-13 1980-10-07 Miles Laboratories, Inc. β-Galactosyl-umbelliferone-labeled aminoglycoside antibiotics and intermediates in their preparation
DK0888292T3 (da) 1996-03-20 2002-02-18 Genentech Inc Tricykliske forbindelser med virkning over for integriner, især alphavbeta3 integriner, fremgangsmåde til deres fremstilling, mellemprodukter deraf, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
TW538046B (en) * 1998-01-08 2003-06-21 Hoechst Marion Roussel Inc Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof

Also Published As

Publication number Publication date
CN1269833C (zh) 2006-08-16
TR200002009T2 (tr) 2001-05-21
AU1973699A (en) 1999-07-26
NO20003496L (no) 2000-09-08
CN1502617A (zh) 2004-06-09
AP2000001857A0 (en) 2000-09-30
RS50047B (sr) 2008-11-28
US6420538B1 (en) 2002-07-16
SI1045856T1 (en) 2003-08-31
EA200000749A1 (ru) 2000-12-25
PE20000175A1 (es) 2000-03-09
SK284734B6 (sk) 2005-10-06
WO1999035155A1 (fr) 1999-07-15
DK1045856T3 (da) 2003-07-21
CN1291988A (zh) 2001-04-18
BR9906819A (pt) 2000-10-17
SK10152000A3 (sk) 2001-07-10
SA99191247B1 (ar) 2006-09-20
CN1257164C (zh) 2006-05-24
ID27558A (id) 2001-04-12
NO20003496D0 (no) 2000-07-07
ATE236918T1 (de) 2003-04-15
DE69906684T2 (de) 2003-11-06
CA2317951A1 (fr) 1999-07-15
TNSN99003A1 (fr) 2005-11-10
JP2002500229A (ja) 2002-01-08
EP1045856A1 (fr) 2000-10-25
YU42700A (sh) 2002-12-10
KR100604290B1 (ko) 2006-07-28
DE69906684D1 (de) 2003-05-15
PT1045856E (pt) 2003-08-29
ES2192031T3 (es) 2003-09-16
PL193130B1 (pl) 2007-01-31
CZ20002523A3 (cs) 2000-11-15
CZ299840B6 (cs) 2008-12-10
HUP0100847A1 (hu) 2001-07-30
TW538046B (en) 2003-06-21
EP1045856B1 (fr) 2003-04-09
HUP0100847A3 (en) 2003-07-28
NZ505523A (en) 2003-01-31
US6583119B2 (en) 2003-06-24
IL137201A0 (en) 2001-07-24
CO4810298A1 (es) 1999-06-30
DZ2702A1 (fr) 2003-09-01
AU750742B2 (en) 2002-07-25
EA003275B1 (ru) 2003-04-24
KR20010033939A (ko) 2001-04-25
US20030060609A1 (en) 2003-03-27
MA26593A1 (fr) 2004-12-20
PA8466601A1 (es) 2000-05-24
PL341590A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
AR015211A1 (es) Amidas aromaticas, su procedimiento de preparacion, composicion farmaceutica y productos quimicos que las contienen
AR004195A1 (es) Nuevos derivados de la 5-0 desosaminil-6-0-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios, metodo de aplicacionde los mismos para la preparacion de productos biologicamente activos.
ES2085627T3 (es) Nuevos derivados de perhidroisoindol, su preparacion y las composiciones farmaceuticas que les contienen.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
AR018844A1 (es) Composicion desinfectante y proceso para desinfectar superficies
MX9101445A (es) Composiciones de organosilicio que contienen elastomeros hidrocarburo
ES2057488T3 (es) Nuevos derivados de la isoindolona y su preparacion.
ES2110421T3 (es) O-bencil-oximeteres y los agentes protectores de las plantas que contienen estos compuestos.
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
ES2167903T3 (es) Estabilizantes frente a los uv para sistemas de siloxano.
ES2101513T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
CO4700298A1 (es) Derivados de 3-fenilisoquinoleina-1 (2h)-ona, su preparacion y su aplicacion en la terapeutica
ES2059845T3 (es) Composiciones que contienen fosforo-nitruro-cloruros.
ECSP930948A (es) Fenilbenzamidas fungicidas y procedimientos para prepararlas
AR004965A1 (es) Procedimiento de preparacion de derivados de fenilimidazolidina
ID24978A (id) 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
ES2062846T3 (es) Compuestos organicos de silicio que tienen grupos (met)acriloxi, su preparacion y utilizacion.
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2076781T3 (es) Procedimiento para la preparacion de compuestos de organosilicio que presentan radicales organicos con contenido en azufre.
AR008228A1 (es) Derivados aromaticos sustituidos con un radical de ribosa, su procedimiento de preparacion, compuestos intermediarios para su exclusivo uso en dicho procedimiento, medicamentos y composiciones farmaceuticas.
MX9301985A (es) Derivados de perhidroisoindol y procedimiento para su preparacion.
ES2121395T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2038776T3 (es) Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal